Safety and Effect of Intravitreal Injection of a Derivative of Nucleoside Reverse Transcriptase Inhibitor in Subjects with Diabetic Macular Edema
Clinical trial NCT05699759 · COMPLETED
Trial details
- NCT number
- NCT05699759
- Sponsor
- Michelle Abou-Jaoude
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-04
- Primary completion
- 2024-06-20
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.